Related references
Note: Only part of the references are listed.Protein-based nanoparticles for drug delivery purposes
Ana L. Martinez-Lopez et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Zein-based nanoparticles for the oral delivery of insulin
Laura Inchaurraga et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration
Laura Inchaurraga et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
The C. elegans intestine: organogenesis, digestion, and physiology
Ivan Dimov et al.
CELL AND TISSUE RESEARCH (2019)
Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel
Luisa Ruiz-Gaton et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
Mohammad Hassan Baig et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
Craig S. Schneider et al.
SCIENCE ADVANCES (2017)
THPdb: Database of FDA-approved peptide and protein therapeutics
Salman Sadullah Usmani et al.
PLOS ONE (2017)
Piceatannol extends the lifespan of Caenorhabditis elegans via DAF-16
Peiyi Shen et al.
BIOFACTORS (2017)
The influence of small intestinal mucus structure on particle transport ex vivo
Balazs H. Bajka et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Nanoparticle diffusion within intestinal mucus: Three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles
Muthanna Abdulkarim et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration
Laura Inchaurraga et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Glucose Induces Sensitivity to Oxygen Deprivation and Modulates Insulin/IGF-1 Signaling and Lipid Biosynthesis in Caenorhabditis elegans
Anastacia M. Garcia et al.
GENETICS (2015)
Zein nanoparticles for oral folic acid delivery
Rebeca Penalva et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2015)
Establishing Caenorhabditis elegans as a model for Mycobacterium avium subspecies hominissuis infection and intestinal colonization
Jamie L. Everman et al.
BIOLOGY OPEN (2015)
daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans
Michael Mendler et al.
DIABETOLOGIA (2015)
Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: Strategies and industrial perspectives
Vivek K. Pawar et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Laura M. Ensign et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN)
S. Doktorovova et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid)
Tao Yu et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
Fat accumulation in Caenorhabditis elegans is mediated by SREBP homolog SBP-1
Toshihisa Nomura et al.
GENES AND NUTRITION (2010)
A Comparative Study of Fat Storage Quantitation in Nematode Caenorhabditis elegans Using Label and Label-Free Methods
Kelvin Yen et al.
PLOS ONE (2010)
Glucose Shortens the Life Span of C. elegans by Downregulating DAF-16/FOXO Activity and Aquaporin Gene Expression
Seung-Jae Lee et al.
CELL METABOLISM (2009)
C-elegans as Model for the Study of High Glucose-Mediated Life Span Reduction
Andreas Schlotterer et al.
DIABETES (2009)
The Spectrum of Diabetic Neuropathies
Jennifer A. Tracy et al.
PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA (2008)
Current challenges in non-invasive insulin delivery systems: A comparative review
El-Sayed Khafagy et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress
Tim J. Schulz et al.
CELL METABOLISM (2007)
Share Paper
